VANGUARD GROUP INC 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 2:33 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | 0 (Unchanged) | Filing |
| 2024-11-04 1:08 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | 0 (Unchanged) | Filing |
| 2024-11-04 12:11 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | -1,161,788 (-16.49%) | Filing |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 7,044,149 7.160% | -2,399,920 (-25.41%) | Filing |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 9,444,069 10.050% | 58,880 (+0.63%) | Filing |
| 2022-03-09 08:44 am Purchase | 2022-02-28 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 9,385,189 10.090% | 349,001 (+3.86%) | Filing |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 9,036,188 9.750% | 1,471,242 (+19.45%) | Filing |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 7,564,946 8.310% | 536,519 (+7.63%) | Filing |